Ortrud Quarder

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignees: Roche Diagnostics Operations, Inc., Roche Diabetes Care, Inc.. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ortrud Quarder. Retrieved from https://idiyas.com/inventor/ortrud-quarder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 57.1

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 3)

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 20(Granted Patents)

Company Filing History:

4 out of 1,698

Roche Diagnostics Operations, Inc.

patents

3 out of 665

Roche Diabetes Care, Inc.

patents

Years Active: 2010-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10892040 - Method for evaluating a set of measurement data from an oral glucose tolerance test (2021-01-12),

2. 10390743 - Electrode system for measuring an analyte concentration under in-vivo conditions (2019-08-27),

3. 9394563 - Electrode system for measuring an analyte concentration under in-vivo conditions (2016-07-19),

4. 8394035 - Multi-lancet device (2013-03-12),

5. 8231547 - Puncturing system for withdrawing a body fluid (2012-07-31),

6. 8114623 - Method for determining glucose concentration in tissue fluid (2012-02-14),

7. 7771367 - Lancet wheel (2010-08-10),

Title: Ortrud Quarder: Pioneering Innovations for a Healthier Future

Introduction:

Ortrud Quarder, a distinguished inventor based in Heidelberg, Germany, has become a preeminent figure in the realm of inventions through his unwavering dedication to advancing technologies aimed at enhancing our quality of life.

Latest Patents:

With a remarkable portfolio of 7 patents, Ortrud Quarder's latest inventions include a groundbreaking method for evaluating measurement data from oral glucose tolerance tests. This method employs sophisticated algorithms to analyze glucose concentration profiles, revolutionizing the assessment of glucose metabolism in patients. Additionally, his electrode system for measuring analyte concentrations in vivo showcases his expertise in developing cutting-edge biomedical devices with enhanced accuracy and reliability.

Career Highlights:

Having made significant contributions to companies such as Roche Diagnostics Operations, Inc. and Roche Diabetes Care, Inc., Ortrud Quarder has played a pivotal role in driving innovation within the healthcare industry. His inventive solutions have paved the way for more precise diagnostics and monitoring tools, significantly impacting patient care worldwide.

Collaborations:

Throughout his esteemed career, Ortrud Quarder has collaborated with esteemed professionals in the field, including Arnulf Staib and Hans-Peter Haar. Together, they have leveraged their collective expertise to push the boundaries of innovation and bring forth groundbreaking technologies that address critical healthcare needs.

Conclusion:

Ortrud Quarder's relentless pursuit of innovation and his passion for creating a better future have firmly established him as a trailblazer in the world of inventions. His visionary approach to problem-solving and his commitment to advancing healthcare technologies exemplify the true spirit of innovation. As Ortrud Quarder continues to push the boundaries of what is possible, the impact of his work on the field of biomedical inventions is bound to shape the future of healthcare for years to come.

Profile summary based on public USPTO records.